CA3305948A1 - Compositions pour le traitement du cancer - Google Patents

Compositions pour le traitement du cancer

Info

Publication number
CA3305948A1
CA3305948A1 CA3305948A CA3305948A CA3305948A1 CA 3305948 A1 CA3305948 A1 CA 3305948A1 CA 3305948 A CA3305948 A CA 3305948A CA 3305948 A CA3305948 A CA 3305948A CA 3305948 A1 CA3305948 A1 CA 3305948A1
Authority
CA
Canada
Prior art keywords
compositions
treating cancer
cancer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3305948A
Other languages
English (en)
Inventor
Kevin M. Friedman
Molly R. Perkins
Connor S. Dobson
Stephen L. SAZINSKY
Shannon G. Contrastano
Emily Thompson Beura
Cory Ahonen
Andrew Avery
Original Assignee
Kelonia Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kelonia Therapeutics Inc filed Critical Kelonia Therapeutics Inc
Publication of CA3305948A1 publication Critical patent/CA3305948A1/fr
Pending legal-status Critical Current

Links

CA3305948A 2023-09-25 2024-09-25 Compositions pour le traitement du cancer Pending CA3305948A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/540,336 2023-09-25
US63/618,878 2024-01-08

Publications (1)

Publication Number Publication Date
CA3305948A1 true CA3305948A1 (fr) 2025-04-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP3938354A4 (fr) Compositions et méthodes de traitement du cancer
AU2024353718A1 (en) Compositions for treating cancer
EP4025590A4 (fr) Procédés et compositions pour le traitement du cancer
CA3264256A1 (fr) Composés pour le traitement du cancer
EP3930705A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3968785A4 (fr) Compositions et méthodes de traitement du cancer
EP3962919A4 (fr) Composés pour traiter le cancer
CA3262155A1 (fr) Composés pour le traitement du cancer
CA3256727A1 (fr) Compositions pour le traitement de xlmtm
EP4077690A4 (fr) Méthodes et compositions de traitement du cancer
EP4149508A4 (fr) Compositions et méthodes de traitement du cancer
EP3984553A4 (fr) Composition pour prévenir ou traiter le cancer
EP4243835A4 (fr) Compositions et méthodes de traitement de cancer solide
HK40119443A (en) Compositions for treating xlmtm
CA3308038A1 (fr) Compositions pour traiter le cancer
CA3308723A1 (fr) Compositions et procedes permettant de traiter le cancer
CA3296990A1 (fr) Compositions et méthodes pour traiter le cancer
CA3291233A1 (fr) Méthodes et compositions pour le traitement du cancer
CA3278391A1 (fr) Compositions et méthodes pour traiter le cancer
CA3267333A1 (fr) Compositions et méthodes pour traiter le cancer
EP4534668A4 (fr) Composition pour le traitement du cancer
AU2024410299A1 (en) Methods for treating cancer
CA3274939A1 (fr) Méthodes de traitement du cancer exprimant dll3
CA3219579A1 (en) Methods for treating myc-amplified cancer
HK40129670A (en) Methods for treating cancer